A randomized, double-blind placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia - Archimbaud, E; Ottmann, OG; Yin, JA (Blood, 1999)
et al.